OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 391 - 400 of 797 studies

Eye

Investigation of genetic susceptibility to retinal toxicity in patients taking hydroxychloroquine

Hydroxychloroquine (HCQ) is widely used for joint and skin disorders. It is also being investigated for the possible prevention and/or treatment of COVID19 [1]. However in some patients long-term HCQ use, for joint and skin disorders, can lead to the retina (part of the eye) becoming damaged (HCQ retinopathy), leading to irreversible blindness. In the UK, regular retinal screening is recommended for those taking HCQ, costing the NHS millions per year. Unfortunately, this only identifies the problem after it has ...

GO TO STUDY Go

Cancer and neoplasms

MITHRIDATE: A phase III, randomised, open-label, Multicenter International Trial comparing ruxolitinib with either HydRoxycarbamIDe or interferon Alpha as first line ThErapy for high risk polycythemia vera

Polycythemia vera (PV) is a rare blood cancer characterised by a high-risk of thrombosis (clotting) and haemorrhage (bleeding). Average survival in high-risk patients receiving contemporary care is 10.9 years. Current treatments include aspirin, venesection (blood drawing) and selected use of standard therapies (hydroxycarbamide (HC) or interferon alpha (IFNa)). The strategies remain less than perfect, with on-going risks of developing blood clots, bleeding, dying early due to either these events or to the disease progressing into leukaemia or a more aggressive ...

GO TO STUDY Go

Cancer and neoplasms

Optimisation of breast cancer detection using X-rays

Anonymised copies of normal and abnormal digital mammograms are collected from clinical sites. Real and simulated images of lesions are used to measure the ability of radiologists to detect breast cancer when various technical factors are adjusted.

GO TO STUDY Go

Neurological

A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB101/ION464 Administered Intrathecally to Adults with Multiple System Atrophy (MSA). (HORIZON)

This is a first-in-human, randomised (treatment is assigned by chance), study to evaluate the safety, tolerability and the pharmacokinetics [how a drug is processed] (PK) of multiple doses of the study drug (BIIB101) in adults with Multiple System Atrophy (MSA). Participants will receive either the study drug or a placebo (medication made of an inactive material). The study drug has been tested in animals but, since the study drug has not yet been tested in humans, the safety in ...

GO TO STUDY Go

Reproductive health and childbirth

Evaluation of Laboratory Methods for Measuring the Composition of Breast Milk

Aim: To establish laboratory tests for measuring the composition of human breast milk Outline of research: This study involves the collection of 1-2 teaspoons of breast milk (up to 10 mls) from up to 30 women who are already expressing milk for their babies in the Oxford Newborn Care Unit, Women’s Centre, John Radcliffe Hospital, Oxford The women are healthy volunteers and are recruited by virtue that their babies are NHS patients. Duration of participant involvement will be around 45 min. ...

GO TO STUDY Go

Cancer and neoplasms

An open-label Phase I/IIa study to evaluate the safety and efficacy of CCS1477 as monotherapy in patients with advanced haematological malignancies.

CCS1477 is a new experimental medication (sponsored by CellCentric Ltd) for a group of cancers that effect the blood and/or bone marrow. These include Acute Myeloid Leukaemia (AML), high-risk Myelodysplastic Syndrome (MDS), Multiple Myeloma (MM) and Non-Hodgkin Lymphoma (NHL). It is aimed at tumours that are not responsive to, or have become resistant to, existing medications used in late stage disease. The purpose of this study is to examine the safety, tolerability, pharmacokinetics (PK) and efficacy of CCS1477 when treating patients ...

GO TO STUDY Go

Neurological

The PURA Global Network. Understanding PURA syndrome. PURA Syndrome Longitudinal Natural History Study (a Musketeers Memorandum study

PURA Syndrome was first described in 2014 in a small cohort of children, and since then just over 250 individuals have been identified to have the condition internationally. PURA syndrome typically causes severe developmental delay and intellectual disability. Many also suffer with hypotonia (severe floppiness), feeding difficulties and breathing abnormalities in infancy, and many develop seizures in early childhood. We are designing a longitudinal natural history study, with the aim to collect medical data on individuals with PURA Syndrome. We ...

GO TO STUDY Go

Cancer and neoplasms Oral and Gastrointestinal

Deep Liver Phenotyping & Immunology Study

Hepatocellular carcinoma (HCC) and cholangiocarcinoma are the two most common causes of primary liver cancer and HCC is the second highest cause of cancer death worldwide. It is known that most of these cancers occur in patients who already have a liver condition. Despite close monitoring of many patients who have liver disease with regular ultrasound scans, HCC and cholangiocarcinoma are often discovered at a late stage. This is because they rarely cause symptoms until they have ...

GO TO STUDY Go

Cancer and neoplasms

FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma

FaR-RMS is an over-arching study for children and adults with newly diagnosed and relapsed rhabdomyosarcoma (RMS). It is a multi-arm, multi-stage format, involving several different trial questions. FaR-RMS is intended to be a rolling programme of research with new treatment arms being introduced dependant on emerging data and innovation. This study has multiple aims. It aims to evaluate the impact of new agent regimens in both newly diagnosed and relapsed RMS; whether changing the duration of maintenance therapy affects outcome; and whether changes to dose, extent ...

GO TO STUDY Go

Oral and Gastrointestinal

Phase IIb, randomised, double-blind, placebo-controlled, multi-centre trial of infliximab with transcriptomic biomarker and mechanism evaluation in patients with acute pancreatitis

Acute pancreatitis is a serious condition in which the pancreas becomes inflamed and is damaged. It causes intense abdominal pain and may lead to multiple organ failure. Those suffering from the disease may need help with breathing, heart and kidney function. One out of twenty patients with acute pancreatitis dies, which is more likely to happen to those who develop organ failure. Treatment can be prolonged, often with extended stays in hospital of many weeks. To date many drugs have ...

GO TO STUDY Go